Category: D.C. Diagnosis

After nine months, an update on NIH’s long Covid research

December 22, 2022 STAT Off Biotech, Congress, coronavirus, D.C. Diagnosis, hospitals, Human Health, insurance, Joe Biden, Life Sciences, Medicaid, Medicare, Medicine, Politics, public health, Science and Research, White House

You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…

Biden administration unveils dashboard to track nonfatal drug overdoses

December 8, 2022 STAT Off addiction, Biotech, D.C. Diagnosis, government agencies, Health, Human Health, Life Sciences, Medicine, Science and Research

The Biden administration is rolling out a new tool meant to help prevent drug deaths:…

FDA proposes new rules for which foods can be called ‘healthy’

September 28, 2022 STAT Off Biotech, D.C. Diagnosis, FDA, food, Health, Human Health, Life Sciences, Medicine, Nutrition, Science and Research

The Food and Drug Administration wants to update its rules for which foods can be…

Health funding battles, a nutrition policy overhaul, and two CBD developments

September 27, 2022 STAT Off Biotech, cbd, Congress, D.C. Diagnosis, Human Health, Life Sciences, Medicare, Medicine, mental health, policy, Science and Research, White House

You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…

‘Disaster to disaster’: Underinvestment in public health systems obstructs response to Covid, monkeypox, Walensky says

September 23, 2022 STAT Off Biotech, D.C. Diagnosis, Health, Human Health, Life Sciences, Medicine, Science and Research, Uncategorized

For the record, Rochelle Walensky, director of the Centers for Disease Control and Prevention, would…

Democrats’ TGIF moment, pathologists defend their turf, & Biogen’s back at the FDA’s doorstep

August 11, 2022 STAT Off Biotech, clinical trials, Congress, D.C. Diagnosis, dementia, Human Health, Life Sciences, Medicine, physicians, research, Science and Research, White House

You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…

A chaotic sprint to lower insulin prices and AIDS activists go after Biden on monkeypox

August 2, 2022 STAT Off advocacy, Biotech, Congress, D.C. Diagnosis, Human Health, Joe Biden, Life Sciences, Medicine, monkeypox, NIH, research, Science and Research, tobacco, White House

You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…

The view on drug pricing from Wall Street, a pharma-friendly Dem holds firm, and what’s next for a big telehealth bill

July 28, 2022 STAT Off advocacy, Biotech, Congress, D.C. Diagnosis, drug pricing, Human Health, Joe Biden, Life Sciences, Medicare negotiation, Medicine, Science and Research, White House

You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…

PhRMA and BIO descend on D.C. & unpacking the Senate’s FDA funding drama

July 19, 2022 STAT Off advocacy, Biotech, Congress, D.C. Diagnosis, drug pricing, Human Health, Life Sciences, Medicine, Science and Research, tobacco, White House

You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…

The unlikely crusader who’s winning the fight to lower hospital prices

June 30, 2022 STAT Off advocacy, Biotech, Congress, D.C. Diagnosis, drug pricing, Human Health, Life Sciences, Medicine, Science and Research, states, White House

You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…

The Senate health committee finally marks up its user fee bill

June 14, 2022 STAT Off advocacy, Biotech, Congress, D.C. Diagnosis, drug pricing, FDA, FTC, Human Health, Life Sciences, Medicine, NIH, Science and Research

You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…

California senators advance three bills meant to crack down on health insurers

May 26, 2022 STAT Off Biotech, Congress, coronavirus, D.C. Diagnosis, drug pricing, hospitals, Human Health, insurance, Life Sciences, Medicine, Science and Research

You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…

A no good, very bad week for the FDA

May 25, 2022 STAT Off Biotech, Congress, D.C. Diagnosis, drug pricing, FDA, Human Health, Life Sciences, Medicine, monkeypox, Science and Research, White House

You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…

AstraZeneca’s ambitious vaccine dreams are finally, officially dead

May 19, 2022 STAT Off advocacy, Biotech, Congress, coronavirus, D.C. Diagnosis, drug pricing, Human Health, Life Sciences, Medicare, Medicine, Science and Research, White House

You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…

As Congress takes up FDA oversight of dietary supplements, a lobbying showdown looms

May 17, 2022 STAT Off advocacy, Biotech, campaigns, Congress, coronavirus, D.C. Diagnosis, drug development, FDA, Human Health, Joe Biden, Life Sciences, Medicine, Science and Research, White House

You’re reading the web edition of D.C. Diagnosis, STAT’s weekly newsletter about the politics and…

Pharma showers John Thune with campaign cash

May 10, 2022 STAT Off advocacy, Biotech, campaigns, Congress, D.C. Diagnosis, drug pricing, Human Health, Life Sciences, Medicine, Pharmaceuticals, Science and Research

You’re reading the web edition of D.C. Diagnosis, STAT’s weekly newsletter about the politics and…

The FDA’s Rob Califf on importing drugs from Canada, on Aduhelm, and on opioids

May 3, 2022 STAT Off Biotech, Congress, D.C. Diagnosis, dementia, drug pricing, FDA, Human Health, Life Sciences, Medicine, Science and Research, states, telehealth

You’re reading the web edition of D.C. Diagnosis, STAT’s weekly newsletter about the politics and…

The FDA’s ban on menthol in cigarettes clears a major regulatory hurdle

April 26, 2022 STAT Off Biotech, coronavirus, D.C. Diagnosis, drug pricing, FDA, Human Health, Life Sciences, Medicine, Science and Research, White House

D.C. Diagnosis is STAT’s weekly newsletter about the politics and policy of health and medicine….

Biogen’s head-scratching new lobbyist hire

April 19, 2022 STAT Off advocacy, Biotech, cancer, Congress, coronavirus, D.C. Diagnosis, drug pricing, Human Health, Life Sciences, Medicine, Science and Research, White House

D.C. Diagnosis is STAT’s weekly newsletter about the politics and policy of health and medicine….

The next battle in the never-ending war over Aduhelm

April 14, 2022 STAT Off Biotech, D.C. Diagnosis, dementia, drug pricing, FDA, finance, Human Health, legal, Life Sciences, Medicine, Science and Research

You’re reading the web edition of D.C. Diagnosis, STAT’s weekly newsletter about the politics and…

Faced with high drug prices, seniors are abandoning cancer drugs at the pharmacy

April 5, 2022 STAT Off Biotech, Congress, D.C. Diagnosis, dementia, drug pricing, FDA, Human Health, Life Sciences, Medicare, Medicine, Science and Research, White House

The pressure on Medicare just keeps ramping up Medicare is set to decide this month…

Before Aduhelm, Billy Dunn was a superstar at the FDA

March 22, 2022 STAT Off Biotech, Congress, D.C. Diagnosis, dementia, drug pricing, hospitals, Human Health, Life Sciences, Medicine, neurology, Science and Research, White House

You’re reading the web edition of D.C. Diagnosis, STAT’s weekly newsletter about the politics and…

Inside the push for a permanent pandemic preparedness office at the White House

March 15, 2022 STAT Off advocacy, Biotech, Congress, coronavirus, D.C. Diagnosis, drug pricing, Human Health, Life Sciences, Medicare, Medicine, Science and Research, White House

You’re reading the web edition of D.C. Diagnosis, STAT’s weekly newsletter about the politics and…

Covid budget crunch looms over government funding fight

March 8, 2022 STAT Off Biotech, Congress, coronavirus, D.C. Diagnosis, drug pricing, FDA, Human Health, Joe Biden, Life Sciences, Medicine, Science and Research, tobacco, White House

You’re reading the web edition of D.C. Diagnosis, STAT’s weekly newsletter about the politics and…

The FDA’s promised menthol ban is about to face a critical test

March 1, 2022 STAT Off Biotech, Congress, coronavirus, D.C. Diagnosis, FDA, Human Health, Joe Biden, Life Sciences, Medicine, Science and Research, White House

You’re reading the web edition of D.C. Diagnosis, STAT’s weekly newsletter about the politics and…

What does the Build Back Better Act actually mean for the health care industry?

November 23, 2021 STAT Off Biotech, Congress, D.C. Diagnosis, drug pricing, Human Health, Life Sciences, Medicare negotiation, Medicine, Science and Research, White House

You’re reading the web edition of D.C. Diagnosis, STAT’s weekly newsletter about the politics and…

Which drug maker spent the most on lobbying this summer? The answer will surprise you

October 26, 2021 STAT Off advocacy, Biotech, Congress, coronavirus, D.C. Diagnosis, drug pricing, Human Health, Life Sciences, Medicine, Pharmaceuticals, Science and Research

You’re reading the web edition of D.C. Diagnosis, STAT’s weekly newsletter about the politics and…

Scott Gottlieb: Trump’s shadow FDA commissioner during Covid-19?

September 21, 2021 STAT Off Biotech, D.C. Diagnosis, drug pricing, FDA, Human Health, Life Sciences, Medicine, Science and Research, White House

You’re reading the web edition of D.C. Diagnosis, STAT’s weekly newsletter about the politics and…

Congress is ready to dig into drug prices

September 7, 2021 STAT Off Biotech, Congress, D.C. Diagnosis, drug pricing, Human Health, Life Sciences, Medicine, Science and Research, White House

You’re reading the web edition of D.C. Diagnosis, STAT’s weekly newsletter about the politics and…

What happened to the FDA’s toughest regulator?

July 27, 2021 STAT Off Biotech, Congress, D.C. Diagnosis, dementia, drug pricing, FDA, Human Health, Joe Biden, Life Sciences, Medicine, newsletter-dcd, Science and Research, White House

You’re reading the web edition of D.C. Diagnosis, STAT’s weekly newsletter about the politics and…

Biden wants a drug pricing plan in 45 days. Who’s going to write it? 

July 13, 2021 STAT Off Biotech, Congress, coronavirus, D.C. Diagnosis, dementia, drug pricing, Human Health, Joe Biden, Life Sciences, Medicine, newsletter-dcd, Science and Research, White House

You’re reading the web edition of D.C. Diagnosis, STAT’s weekly newsletter about the politics and…

Are pharma mergers bad for biotech?

July 6, 2021 STAT Off Biotech, Congress, D.C. Diagnosis, drug pricing, Human Health, legal, Life Sciences, Medicine, newsletter-dcd, policy, Science and Research, White House

You’re reading the web edition of D.C. Diagnosis, STAT’s weekly newsletter about the politics and…

Operation Warp Speed — now, the ‘CAG’— is here to stay

June 29, 2021 STAT Off advocacy, Biotech, Congress, coronavirus, D.C. Diagnosis, Human Health, Life Sciences, Medicine, newsletter-dcd, Science and Research, vaccines, White House

You’re reading the web edition of D.C. Diagnosis, STAT’s weekly newsletter about the politics and…

The lonely quest to create a commission to investigate Covid-19

June 22, 2021 STAT Off advocacy, Biotech, coronavirus, D.C. Diagnosis, Human Health, Life Sciences, Medicine, newsletter-dcd, policy, Science and Research, White House

You’re reading the web edition of D.C. Diagnosis, STAT’s weekly newsletter about the politics and…

STAT+: There’s no point person in Biden’s HHS for its $186 billion Covid-19 fund for health care providers

April 6, 2021 STAT Off Biotech, Congress, D.C. Diagnosis, Human Health, Life Sciences, Medicine, policy, Politics, providers, Science and Research, STAT+, White House

WASHINGTON — Health care providers are eagerly awaiting billions of dollars from a Covid-19 relief…

STAT+ Conversations: The D.C. Diagnosis

September 22, 2020 STAT Off Biotech, D.C. Diagnosis, FDA, government agencies, Human Health, Life Sciences, Medicine, Pharmaceuticals, policy, Science and Research, STAT+ Conversations, White House

Each week, STAT Plus subscribers get exclusive access to live discussions with STAT reporters and…

STAT+ Conversations: How pharma is influencing the 2020 election

August 11, 2020 STAT Off Biotech, D.C. Diagnosis, Human Health, Life Sciences, Medicine, policy, Prescription Politics, Science and Research, STAT+ Conversations

Editor’s note: A livestream of this conversation will be embedded above at 1 p.m. ET. …